Understanding how nematodes determine their sex
Analysis of Nematode Sex Determination and Dosage Compensation
This study looks at how tiny worms called C. elegans decide whether to become male or hermaphrodite based on the number of X chromosomes they have, using smart computer techniques to understand the details, which might help us learn more about similar processes in other living things.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10598121 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the nematode C. elegans determines its sex through the ratio of X chromosomes to autosomes. By employing advanced machine learning techniques and single-cell analysis, the study aims to uncover how these ratios lead to the development of either male or hermaphrodite forms, while preventing intersexuality. The research also explores the role of chromatin modifications and chromosome structure in regulating gene expression, particularly focusing on X-chromosome dosage compensation. This comprehensive approach could provide insights into fundamental biological processes that may have broader implications.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic conditions related to sex determination or chromosomal abnormalities.
Not a fit: Patients with unrelated genetic conditions or those not affected by sex determination issues may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of sex determination and dosage compensation, potentially leading to advancements in genetic therapies and treatments for related disorders.
How similar studies have performed: Previous research has shown success in understanding genetic mechanisms in model organisms like C. elegans, indicating that this approach is grounded in established scientific methods.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Meyer, Barbara J — University of California Berkeley
- Study coordinator: Meyer, Barbara J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.